Abiopharma

Tom Penny 🟡 adjusted position in 443.5K shares (1 derivative) of Equillium, Inc. (EQ) at $1.31 Transaction Date: Jan 07, 2026 | Filing ID: 000001

ArrowMark Financial Corp. Announces Monthly Cash Distribution of $0.15 per Share for January 2026

New Form S-3 - Immix Biopharma, Inc. Filed: 2026-01-09 AccNo: 0001493152-26-001159 Size: 1 MB

Director MISSLING CHRISTOPHER U 🟢 acquired 125.0K shares (1 derivative) of ANAVEX LIFE SCIENCES CORP. (AVXL) at $8.58 ($1.1M) Transaction Date: Jan 06, 2026 | Filing ID: 000036

(75% Positive) Vistagen Therapeutics, Inc. (VTGN) Announces Clinical Development Update

Boenisch Sandra 🟢 acquired 12.5K shares (1 derivative) of ANAVEX LIFE SCIENCES CORP. (AVXL) at $8.58 Transaction Date: Jan 06, 2026 | Filing ID: 000035

Silver Point Capital L.P. 🟢 acquired 250.0K shares of Keenova Therapeutics plc (NONE) at $92.25 ($23.1M) Transaction Date: Jan 07, 2026 | Filing ID: 009126

New Form PRE 14A - Healthcare Triangle, Inc. Filed: 2026-01-09 AccNo: 0001213900-26-002983 Size: 3 MB

New Form SCHEDULE 13G - Mereo BioPharma Group plc Filed: 2026-01-09 AccNo: 0000935836-26-000022 Size: 16 KB

New Form S-3 - ALLURION TECHNOLOGIES, INC. Filed: 2026-01-09 AccNo: 0001193125-26-009121 Size: 519 KB

(99% Neutral) Enveric Biosciences, Inc. (ENVB) Files Form 8-K

New Form 425 - Semler Scientific, Inc. Filed: 2026-01-09 AccNo: 0001104659-26-002539 Size: 64 KB

(10% Negative) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces Delay in pathway Trials for registration Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(90% Positive) ANAPTYSBIO, INC (ANAB) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Director WEISS MICHAEL S 🟢 acquired 622.0K shares of TG THERAPEUTICS, INC. (TGTX) Transaction Date: Jan 08, 2026 | Filing ID: 001016